Increased energy expenditure and leptin sensitivity account for low fat mass in myostatin-deficient mice

American Journal of Physiology - Endocrinology and Metabolism

Volumn 300, Issue 6, 2011, Pages

  Choi, Sun Ju ^a,d   Yablonka Reuveni, Zipora ^b   Kaiyala, Karl J ^c   Ogimoto, Kayoko ^a   Schwartz, Michael W ^a   Wisse, Brent E ^a  

^a Diabetes and Obesity Center of Excellence   (United States)

^b Department of Biological Structure ^*

^c UNIVERSITY OF WASHINGTON   (United States)

^d Yonsei University Wonju College of Medicine   (South Korea)

Author keywords

Body fat; Energy balance; Insulin sensitivity; Locomotor activity

Indexed keywords

LEPTIN; MYOSTATIN;

ANIMAL TISSUE; ANOREXIA; ARTICLE; BODY COMPOSITION; BODY FAT; BODY MASS; CONTROLLED STUDY; ENERGY BALANCE; ENERGY EXPENDITURE; FEMALE; FOOD INTAKE; HETEROZYGOTE; HYPERPHAGIA; MALE; MOUSE; MUSCLE MASS; NONHUMAN; OXYGEN CONSUMPTION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEFICIENCY; REGRESSION ANALYSIS; SENSITIVITY ANALYSIS; WEIGHT REDUCTION; WILD TYPE;

ADIPOSE TISSUE; ANIMALS; BLOTTING, WESTERN; BODY COMPOSITION; BODY WEIGHT; CALORIMETRY, INDIRECT; EATING; ENERGY METABOLISM; FEMALE; GLUCOSE TOLERANCE TEST; LEPTIN; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOTOR ACTIVITY; MYOSTATIN; OXYGEN CONSUMPTION; REGRESSION ANALYSIS;

EID: 79957660667     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00656.2010     Document Type: Article

References (40)

1. Abu-Elheiga L, Matzuk MM, Abo-Hashema KA, Wakil SJ. Continuous fatty acid oxidation and reduced fat storage in mice lacking acetyl-CoA carboxylase 2. Science 291: 2613-2616, 2001.
2. Amthor H, Macharia R, Navarrete R, Schuelke M, Brown SC, Otto A, Voit T, Muntoni F, Vrbova G, Partridge T, Zammit P, Bunger L, Patel K. Lack of myostatin results in excessive muscle growth but impaired force generation. Proc Natl Acad Sci USA 104: 1835-1840, 2007.
3. Arch JR, Hislop D, Wang SJ, Speakman JR. Some mathematical and technical issues in the measurement and interpretation of open-circuit indirect calorimetry in small animals. Int J Obes (Lond) 30: 1322-1331, 2006.
4. Armitage PB, Matthews JN. Statistical Methods in Medical Research. New York: Blackwell Science, 2002.
5. Bence KK, Delibegovic M, Xue B, Gorgun CZ, Hotamisligil GS, Neel BG, Kahn BB. Neuronal PTP1B regulates body weight, adiposity and leptin action. Nat Med 12: 917-924, 2006.
6. Bernardo BL, Wachtmann TS, Cosgrove PG, Kuhn M, Opsahl AC, Judkins KM, Freeman TB, Hadcock JR, LeBrasseur NK. Postnatal PPARdelta activation and myostatin inhibition exert distinct yet complimentary effects on the metabolic profile of obese insulin-resistant mice. PLoS One 5: e11307, 2010.
7. Butler AA, Kozak LP. A recurring problem with the analysis of energy expenditure in genetic models expressing lean and obese phenotypes. Diabetes 59: 323-329, 2010.
8. Day K, Shefer G, Shearer A, Yablonka-Reuveni Z. The depletion of skeletal muscle satellite cells with age is concomitant with reduced capacity of single progenitors to produce reserve progeny. Dev Biol 340: 330-343, 2010.
9. Gelling RW, Yan W, Al-Noori S, Pardini A, Morton GJ, Ogimoto K, Schwartz MW, Dempsey PJ. Deficiency of TNFalpha converting enzyme (TACE/ADAM17) causes a lean, hypermetabolic phenotype in mice. Endocrinology 149: 6053-6064, 2008.
10. Girgenrath S, Song K, Whittemore LA. Loss of myostatin expression alters fiber-type distribution and expression of myosin heavy chain isoforms in slow- and fast-type skeletal muscle. Muscle Nerve 31: 34-40, 2005.
11. Guo T, Jou W, Chanturiya T, Portas J, Gavrilova O, McPherron AC. Myostatin inhibition in muscle, but not adipose tissue, decreases fat mass and improves insulin sensitivity. PLoS One 4: e4937, 2009.
12. Guttridge DC. Signaling pathways weigh in on decisions to make or break skeletal muscle. Curr Opin Clin Nutr Metab Care 7: 443-450, 2004.
13. Hennebry A, Berry C, Siriett V, O'Callaghan P, Chau L, Watson T, Sharma M, Kambadur R. Myostatin regulates fiber-type composition of skeletal muscle by regulating MEF2 and MyoD gene expression. Am J Physiol Cell Physiol 296: C525-C534, 2009.
14. Izumiya Y, Hopkins T, Morris C, Sato K, Zeng L, Viereck J, Hamilton JA, Ouchi N, LeBrasseur NK, Walsh K. Fast/Glycolytic muscle fiber growth reduces fat mass and improves metabolic parameters in obese mice. Cell Metab 7: 159-172, 2008.
15. Joulia-Ekaza D, Cabello G. The myostatin gene: physiology and pharmacological relevance. Curr Opin Pharmacol 7: 310-315, 2007.
16. Kaiyala KJ, Morton GJ, Leroux BG, Ogimoto K, Wisse B, Schwartz MW. Identification of body fat mass as a major determinant of metabolic rate in mice. Diabetes 59: 1657-1666, 2010.
17. Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, Daussin F, Messadeq N, Milne J, Lambert P, Elliott P, Geny B, Laakso M, Puigserver P, Auwerx J. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 127: 1109-1122, 2006.
18. LeBrasseur NK, Schelhorn TM, Bernardo BL, Cosgrove PG, Loria PM, Brown TA. Myostatin inhibition enhances the effects of exercise on performance and metabolic outcomes in aged mice. J Gerontol A Biol Sci Med Sci 64: 940-948, 2009.
19. Lin J, Arnold HB, Della-Fera MA, Azain MJ, Hartzell DL, Baile CA. Myostatin knockout in mice increases myogenesis and decreases adipogenesis. Biochem Biophys Res Commun 291: 701-706, 2002.
20. McLean JT. Animal and Human Calorimetry. New York: Cambridge University, 1987.
21. McMinn JE, Baskin DG, Schwartz MW. Neuroendocrine mechanisms regulating food intake and body weight. Obes Rev 1: 37-46, 2000.
22. McPherron AC, Lawler AM, Lee SJ. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 387: 83-90, 1997.
23. McPherron AC, Lee SJ. Suppression of body fat accumulation in myostatin-deficient mice. J Clin Invest 109: 595-601, 2002.
24. Mendias CL, Marcin JE, Calerdon DR, Faulkner JA. Contractile properties of EDL and soleus muscles of myostatin-deficient mice. J Appl Physiol 101: 898-905, 2006
25. Mori H, Hanada R, Hanada T, Aki D, Mashima R, Nishinakamura H, Torisu T, Chien KR, Yasukawa H, Yoshimura A. Socs3 deficiency in the brain elevates leptin sensitivity and confers resistance to diet-induced obesity. Nat Med 10: 739-743, 2004.
26. Morton GJ, Cummings DE, Baskin DG, Barsh GS, Schwartz MW. Central nervous system control of food intake and body weight. Nature 443: 289-295, 2006.
27. Novak CM, Levine JA. Central neural and endocrine mechanisms of non-exercise activity thermogenesis and their potential impact on obesity. J Neuroendocrinol 19: 923-940, 2007.
28. Packard GC, Birchard GF. Traditional allometric analysis fails to provide a valid predictive model for mammalian metabolic rates. J Exp Biol 211: 3581-3587, 2008.
29. Schmitt D, Zumwalt AC, Hamrick MW. The relationship between bone mechanical properties and ground reaction forces in normal and hypermuscular mice. J Exp Zool A Ecol Genet Physiol 313: 339-351.
30. Schuelke M, Wagner KR, Stolz LE, Hubner C, Riebel T, Komen W, Braun T, Tobin JF, Lee SJ. Myostatin mutation associated with gross muscle hypertrophy in a child. N Engl J Med 350: 2682-2688, 2004.
31. Taicher GZ, Tinsley FC, Reiderman A, and Heiman ML. Quantitative magnetic resonance (QMR) method for bone and whole-body-composition analysis. Anal Bioanal Chem 377: 990-1002, 2003.
32. Tanner JM. Fallacy of per-weight and per-surface area standards, and their relation to spurious correlation. J Appl Physiol 2: 1-15, 1949.
33. Tinsley FC, Taicher GZ, Heiman ML. Evaluation of a quantitative magnetic resonance method for mouse whole body composition analysis. Obes Res 12: 150-160, 2004.
34. Toth MJ. Comparing energy expenditure data among individuals differing in body size and composition: statistical and physiological considerations. Curr Opin Clin Nutr Metab Care 4: 391-397, 2001.
35. Tu P, Bhasin S, Hruz PW, Herbst KL, Castellani LW, Hua N, Hamilton JA, Guo W. Genetic disruption of myostatin reduces the development of proatherogenic dyslipidemia and atherogenic lesions in Ldlr null mice. Diabetes 58: 1739-1748, 2009.
36. White CR, Cassey P, Blackburn TM. Allometric exponents do not support a universal metabolic allometry. Ecology 88: 315-323, 2007.
37. White CR, Seymour RS. Allometric scaling of mammalian metabolism. J Exp Biol 208: 1611-1619, 2005.
38. Wilkes JJ, Lloyd DJ, Gekakis N. Loss-of-function mutation in myostatin reduces tumor necrosis factor alpha production and protects liver against obesity-induced insulin resistance. Diabetes 58: 1133-1143, 2009.
39. Wisse BE, Ogimoto K, Schwartz MW. Role of hypothalamic interleukin- 1beta (IL-1beta) in regulation of energy homeostasis by melanocortins. Peptides 27: 265-273, 2006.
40. Zabolotny JM, Bence-Hanulec KK, Stricker-Krongrad A, Haj F, Wang Y, Minokoshi Y, Kim YB, Elmquist JK, Tartaglia LA, Kahn BB, Neel BG. PTP1B regulates leptin signal transduction in vivo. Dev Cell 2: 489-495, 2002.